Product Information
ZOLMITRIPTAN 5 MG TABLET is a generic product labeled by Medstone Pharma LLC, priced at $1.4228 per EA under NDC 71626010203. Its NADAC has been published 330 times since Mar 4, 2020.
Strength
5 mg/1
Manufacturer
Medstone Pharma LLCNDC
71626010203
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ZOLMITRIPTANApproval Type
Generic (ANDA)
FDA Application
ANDA207867On Market Since
5/30/2018
Pharmacological Classes
Price Statistics
The NADAC for ZOLMITRIPTAN 5 MG TABLET has been published 330 times since Mar 4, 2020, and over the history we have for it it has declined 21.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4228 per EA |
|---|---|
| All-time high | $2.3363 (Aug 12, 2020) |
| All-time low | $1.1137 (May 22, 2024) |
| 52-week high | $1.7765 |
| 52-week low | $1.2261 |
| Median price | $1.5362 |
| Average price | $1.6250 |
| Largest weekly change | +45.4% (Jan 19, 2022) |
| Weeks tracked | 330 |
| Tracking since | Mar 4, 2020 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ZOLMITRIPTAN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 5 MG TABLET, manufactured by Medstone Pharma LLC, is $1.4228 per EA (NDC 71626010203), effective Jun 24, 2026.
How has the price of ZOLMITRIPTAN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZOLMITRIPTAN 5 MG TABLET has declined 21.0%. It has been tracked across 330 weekly CMS publications since Mar 4, 2020.
What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 5 MG TABLET?
Since Mar 4, 2020, the NADAC for ZOLMITRIPTAN 5 MG TABLET has ranged from a low of $1.1137 (May 22, 2024) to a high of $2.3363 (Aug 12, 2020), with a median of $1.5362 per EA.
Are there cheaper alternatives to ZOLMITRIPTAN 5 MG TABLET?
11 NADAC-published products share the same active ingredient, strength, and dosage form as ZOLMITRIPTAN 5 MG TABLET, but none are currently priced below it.
Who manufactures ZOLMITRIPTAN 5 MG TABLET?
ZOLMITRIPTAN 5 MG TABLET (NDC 71626010203) is labeled by Medstone Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification